Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

MYSTERIOUS: What are wall street analysts target price for solventum stock - What They Never Told You

Eagan, Minnesota-based Solventum Corporation (SOLV) is a healthcare company with a market cap of $12.9 billion. It develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs.

This healthcare company has considerably underperformed the broader market over the past 52 weeks. Shares of SOLV have gained 2.7% over this time frame, while the broader S&P 500 Index ($SPX) has soared 26.6%. Moreover, on a YTD basis, the stock is down 3.9%, compared to SPX’s 8.1% rise.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.